Ruth and Tristram Colket Jr. Translational Research Building

3501 Civic Center Blvd
Philadelphia, PA 19104
United States

AddtoAny

The Colket Translational Research Building is part of the Raymond G. Perelman Campus in University City. Featuring flexible laboratory space, Colket is a hub of translational research where top-level scientists further the breakthroughs CHOP strives for every day.

Currently 11 stories, Colket is designed to expand vertically to accommodate future growth. The building achieved Leadership in Energy and Environmental Design certification, an internationally recognized rating system for environmentally responsible buildings.

Colket is within easy walking distance of all CHOP University City locations.

1 - 10 of 402

Small Animal Imaging Facility Core

When you’re in need of radiological imaging for your research, look no further than the Small Animal Imaging Facility at Children’s Hospital.

High Throughput Sequencing Core

The High Throughput Sequencing Core provides access to next-generation sequencing on Illumina® platforms. The staff provides consultation on experimental design, library preparation, and sequencing parameters for a broad range of projects. We are here to listen and create solutions.

Center for Childhood Cancer Research

Improving cure rates and decreasing side effects for children, adolescents, and young adults.

Richard B. Womer, MD

E-mail:

womer [at] chop.edu

Kelly D. Getz, PhD, MPH

Dr. Getz develops and applies advanced methods to enable epidemiologic research that aims to optimize the treatment and supportive care of children with cancer by balancing the therapeutic benefits and toxicity risks with an emphasis in cardio-oncology.

E-mail:

getzk [at] chop.edu

Sharon J. Diskin, PhD

Dr. Diskin's research is focused on translational genomics in childhood cancers. Her laboratory seeks to identify the genetic basis of childhood cancers by combining quantitative computational methods with rigorous "wet-lab" experimental approaches. In parallel, she has developed, and is applying, a proteogenomic approach to identify novel immunotherapeutic targets for high-risk and relapsed pediatric malignancies.

E-mail:

diskin [at] chop.edu

Michael J. Fisher, MD

E-mail:

fisherm [at] chop.edu

Kristopher R. Bosse, MD

The cure rate for children with neuroblastoma is unacceptable, making it imperative that new therapies are developed. Dr. Bosse's laboratory is focused on discovering and developing new neuroblastoma cell surface immunotherapeutic targets. Along with his colleagues, Dr. Bosse's aim is to capitalize on the robust differential expression of these molecules with immune-based therapies and also define their mechanisms of overexpression and roles in tumorigenesis.

E-mail:

bossek [at] chop.edu

Jay Mehta, MD, MS

Dr. Mehta serves as Program Director, Pediatric Rheumatology Fellowship at Children's Hospital of Philadelphia.

E-mail:

mehtaj [at] chop.edu

Jean B. Belasco, MD

Dr. Belasco’s clinical and research work focuses on pediatric cancers, palliative care, neuro-oncology, neurofibromatosis, and lymphatic vascular malformations.

E-mail:

belasco [at] chop.edu